8 October 2021 in Advanced Biology
AAAmir Ehsan Niaraki Asli
+2
Engineering conductive 3D cell scaffoldings offer advantages toward the creation of physiologically relevant platforms with integrated real‐time sensing capabilities. Dopaminergic neural cells are encapsulated into graphene‐laden alginate microfibers using a microfluidic approach, which is unmatched for creating highly‐tunable microfibers. Incorporating graphene increases the conductivity of the alginate microfibers by 148%, creating a similar conductivity to native brain tissue. The cell encapsulation procedure has an efficiency of 50%, and of those cells, ≈30% remain for the entire 6‐day observation period. To understand how the microfluidic encapsulation affects cell genetics, tyrosine hydroxylase, tubulin beta 3 class 3, interleukin 1 beta, and tumor necrosis factor alfa are analyzed primarily with real‐time reverse transcription‐quantitative polymerase chain reaction and secondarily with enzyme‐linked immunosorbent assay, immediately after manufacturing, after encapsulation in polymer matrix for 6 days, and after encapsulation in the graphene‐polymer composite for 6 days. Preliminary data shows that the manufacturing process and combination with alginate matrix affect the expression of the studied genes immediately after manufacturing. In addition, the introduction of graphene further changes gene expressions. Long‐term encapsulation of neural cells in alginate and 6‐day exposure to graphene also leads to changes in gene expressions.
1 January 2023 in Innovation and Emerging Technologies
Striving for sustainable drug discovery, we have presented a proof-of-concept for studying the effects of pharmaceutical agents transported across the placental barrier on neural cells. The potential effects of pharmaceutical agents on fetus have made concerns about their use and require more studies to address these concerns. A placenta-on-a-chip model was fabricated and tested for transport of naltrexone (NTX) and its primary metabolite 6 -naltrexol. The NTX/6 -naltrexol transported from the maternal channel to the fetal channel was then collected from the fetal channel. To evaluate the behavior of neural cells following exposure to NTX and 6 -naltrexol, perfusate from the fetal channel was directed toward the cultured N27 neural cells. Neural cells exposed to the transported NTX/6 -naltrexol were then evaluated for gene expression and cell viability. Results showed significantly higher fold changes in IL-6 and TNF- expression when exposed to NTX/6 -naltrexol. However, a lower fold change in IL-1 expression was observed, while it remained the same in sphingosine kinase (sphk)1. Also, cell viability with NTX/6 -naltrexol exposure was determined to be significantly lower ( ). This study has the potential to reveal the impact of pharmaceutical agents on the developing neural system of fetuses and their premature brains.